» Articles » PMID: 20570887

Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes

Overview
Journal Cancer Res
Specialty Oncology
Date 2010 Jun 24
PMID 20570887
Citations 656
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor-associated macrophages (TAM) form a major component of the tumor stroma. However, important concepts such as TAM heterogeneity and the nature of the monocytic TAM precursors remain speculative. Here, we show for the first time that mouse mammary tumors contained functionally distinct subsets of TAMs and provide markers for their identification. Furthermore, in search of the TAM progenitors, we show that the tumor-monocyte pool almost exclusively consisted of Ly6C(hi)CX(3)CR1(low) monocytes, which continuously seeded tumors and renewed all nonproliferating TAM subsets. Interestingly, gene and protein profiling indicated that distinct TAM populations differed at the molecular level and could be classified based on the classic (M1) versus alternative (M2) macrophage activation paradigm. Importantly, the more M2-like TAMs were enriched in hypoxic tumor areas, had a superior proangiogenic activity in vivo, and increased in numbers as tumors progressed. Finally, it was shown that the TAM subsets were poor antigen presenters, but could suppress T-cell activation, albeit by using different suppressive mechanisms. Together, our data help to unravel the complexities of the tumor-infiltrating myeloid cell compartment and provide a rationale for targeting specialized TAM subsets, thereby optimally "re-educating" the TAM compartment.

Citing Articles

Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?.

Bhatia D, Dolcetti R, Mazzieri R J Exp Clin Cancer Res. 2025; 44(1):98.

PMID: 40089746 DOI: 10.1186/s13046-025-03359-x.


Significant association between systemic inflammation response index and prognosis in patients with urological malignancies.

Ma W, Liu R, Li X, Yu J, Wang W Front Immunol. 2025; 16:1518647.

PMID: 40079014 PMC: 11897710. DOI: 10.3389/fimmu.2025.1518647.


Myeloid cells: key players in tumor microenvironments.

Hua Q, Li Z, Weng Y, Wu Y, Zheng L Front Med. 2025; .

PMID: 40048137 DOI: 10.1007/s11684-025-1124-8.


Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy.

Toghraie F, Bayat M, Hosseini M, Ramezani A Cell Oncol (Dordr). 2025; .

PMID: 39998754 DOI: 10.1007/s13402-025-01051-y.


Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy.

Yang M, Hou S, Chen Y, Chen H, Chu M, Liu S Cancer Immunol Immunother. 2025; 74(3):100.

PMID: 39904769 PMC: 11794739. DOI: 10.1007/s00262-025-03944-1.